Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Wegovy Heart Benefits Touted Amid Growing Concern About Gastrointestinal Risks Novo Nordisk’s findings come as a growing number of users of the weight loss drug are now evaluating potential Wegovy lawsuits over the drug maker’s failure to warn about stomach paralysis risks. August 14, 2023 Irvin Jackson Add Your Comments The makers of Wegovy released new research last week suggesting the diet drug may provide some cardiovascular benefits, reducing the risk of heart attacks and strokes. However, the statements come amid a wave of bad news for Novo Nordisk, and growing concerns about the gastroparesis risk from Wegovy, which has left some users with painful stomach paralysis and other gastrointestinal side effects. Novo Nordisk just introduced Wegovy (semaglutide) in 2021, as a weight loss version of their blockbuster drug Ozempic, which is only FDA approved for treatment of diabetes. However, given the minimal weight loss benefits provided by Wegovy and Ozempic, and a long history of side effects associated with other diet pills, medical experts have raised concerns about the rapid rise in popularity of the drugs. Both Wegovy and Ozempic are part of a class of diabetic medications known as glucagon-like peptide-1 (GLP-1) receptor agonists, which works by slowing the movement of food in the gut to suppress appetite and make users feel full for longer. Although the drugs have been aggressively marketed as safe and effective, a number of users are now coming forward to report that they were left with devastating long-term gastrointestinal problems from Wegovy, Ozempic and other GLP-1 drugs, when used to reduce their weight. The side effects of Wegovy and Ozempic can cause a long-lasting slowing of the movement of food from the stomach to the small intestines, which former users now allege is not adequately disclosed on the drug label. As a result, Novo Nordisk now faces the prospect of a coming wave of Ozempic lawsuits and Wegovy lawsuits, which may be filed in courts nationwide in the coming months. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Wegovy Linked to Reduced Heart Risks, Manufacturer Claims In the face of mounting bad news over the past few weeks, Novo Nordisk issued a press release on August 8, touting the results of a Wegovy cardiovascular clinical trial. The manufacturer says the findings suggest the drug has protective benefits for the heart, reducing the risk of heart attacks, strokes and other cardiovascular problems, which it may use to push for wider use of Wegovy, amid growing concerns over the drug as a weight loss treatment. Novo Nordisk researchers indicate they conducted a double-blind trial comparing a weekly dose of Wegovy with a placebo, involving 17,604 adults age 45 or older who were overweight or obese. The patients had an established history of cardiovascular disease (CVD), but no prior history of diabetes. The drug maker’s study looked for the rate of major adverse cardiovascular events (MACE) over a five-year period. According to the findings, patients who took Wegovy were 20% less likely to suffer heart problems, such as stroke or heart attack, than those given a placebo. The researchers claim the reductions were across the spectrum, leading to fewer incidents of cardiovascular death, non-fatal heart attacks and non-fatal strokes. Novo Nordisk has indicated that it seeks to expand Wegovy’s approval to include prevention of cardiovascular disease in both the U.S. and Europe before the end of the year. Ozempic and Wegovy Stomach Paralysis Risks The positive findings come amid growing awareness among consumers and the medical community about the risk of gastroparesis from Wegovy, Ozempic and similar drugs, when used for weight loss, which could erode sales as more users learn about the potential side effects. Gastroparesis, also known as delayed gastric emptying or stomach paralysis, weakens the normal muscle movement in the stomach. These stomach contractions are necessary to push food through the digestive tract. When gastroparesis occurs, the stomach is slow to empty, resulting in symptoms including nausea, vomiting undigested food, abdominal pain, abdominal bloating, severe dehydration, feeling full after only a few bites, undigested food hardening in the stomach, acid reflux, fluctuating blood sugar levels, lack of appetite, weight loss, malnutrition and decreased quality of life. However, some users are reporting these side effects persisted long after Wegovy or Ozempic are discontinued. Last month, a CNN investigation outlined an alarming number of reports linking Ozempic and stomach paralysis, indicating that similar problems have been associated with other drugs in the same class in recent years. In 2017, researchers with the Mayo Clinic conducted a study involving a similar diabetes medication known as Victoza, which found that the drug caused significantly slower digestion in users, taking about 70 minutes for half the food they ate to leave their stomachs, compared to four minutes for people who did not take the drug. However, the study found that people’s bodies tended to adjust over time. Last month, the American Society of Anesthesiologists (ASA) issued a warning about using Ozempic and Wegovy before surgery, indicating that the lack of gastric emptying linked to the drugs could put patients at risk of vomiting and aspiration while under the effects of anesthesia. Gastroenteritis, also linked to Ozempic and similar drugs, causes inflammation of the stomach and intestines. The condition is usually caused by a virus or as a reaction to certain medications. Symptoms can include vomiting, nausea, diarrhea, stomach cramps, muscle aches, headache, and fever. Health experts warn that diarrhea and vomiting from gastroenteritis can cause severe dehydration, which could result in death. Other Reported Side Effects of Wegovy and Ozempic The new study also follows reports that Ozempic and Wegovy side effects have also been linked to hair loss when using the drugs as weight loss treatment. Some doctors have claimed hair loss after Wegovy use is a natural result of rapid weight loss. This effect is known as telogen effluvium. However, Wegovy may also cause hormonal shifts which can also trigger early onset pattern hair loss in men and women, known as androgenic alopecia, which is progressive and continues to worsen over time. This can lead to permanent hair loss, some health experts warn. In May, the founder of The American Hair Loss Association (AHLA) and The International Alliance of Hair Restoration Surgeons, warned against misuse of Ozempic for weight loss in an editorial in Dermatology Times, indicating that the hair loss experts do not recommend the off-label use of the diabetes drug. In addition, regulators in the European Union warned that Ozempic and Wegovy may be linked to an increased risk of thyroid cancer in June. They called for drug manufacturers to turn in additional data and suggested they may take future actions to address the potential risks. Last week, the first Ozempic lawsuit was filed against Novo Nordisk, involving allegations that the drug maker knew or should have known about the risk of long-term side effects caused by the active ingredient semaglutide, which is also found in Wegovy. Tags: Diabetes, Diabetes Drug, Heart Attack, Heart Disease, Novo Nordisk, Ozempic, Stomach Paralysis, Stroke, Wegovy, Weight Loss Image Credit: | Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study June 23, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 3 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 3 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 4 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)